Posts Tagged Antibody
HUPO PSI-PAR: standard format for protein affinity reagents
Posted by peanutbutter in data standards on April 7, 2009
- Image via Wikipedia
HUPO PSI-PAR: standard format for protein affinity reagents is now available for Public Comment on the PSI Web site for the next 30 days. The public comment period enables the wider community to provide feedback on a proposed standard before it is formally accepted, and thus is an important step in the standardisation process. This message is to encourage you to contribute to the standards development activity by commenting on the material that is available online. We invite both positive and negative comments. If negative comments are being made, these could be on the relevance, clarity, correctness, appropriateness, etc, of the proposal as a whole or of specific parts of the proposal. If you do not feel well placed to comment on this document, but know someone who may be, please consider forwarding this request. There is no requirement that people commenting should have had any prior contact with the PSI. If you have comments that you would like to make but would prefer not to make public, please email the PSI-Editor directly.
All change in 2009, no more academia
Posted by peanutbutter in Uncategorized on January 19, 2009
- Image via Wikipedia
Last week I completed what was my first week of working in academia in 2009 and also my last for the foreseeable future. I have decided to leave academia, as well as Newcastle to take a position in a Biotech company in Cambridge.
I have certainly enjoyed just over 5 years working in Newcastle encompassing my PhD and a postdoc. Within that time my research interests have developed from representing scientific data, to data standards to ontology development. I am still maintaining some of my research interests in my new position. I will be working for an antibody company called Abcam, and as part of my role I will be investigating how to represent their product catalogue as an ontology and how users can have a more direct interaction with it.
I am really looking forward to this fresh challenge. I don’t know how this change of position will effect the content of this blog, although I expect it to still largely reflect my interests on the representation of scientific data and open science. I think its probably safe to assume there might be the odd post about antibodies as well.